Sort
11,323 grants matching “glioblastoma”
Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma
$718,983Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Role of histone variants in aging and cancer
$717,926Yamini P Dalal · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Project 1: Physical modeling and dynamics of tumor cell migration mechanics
$717,814David J Odde · University Of Minnesota · U54 · FY2017 · CA
PET Biomarker for synaptic density changes after radiation therapy
$717,125Mariam Aboian · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Personalized Neural Stem Cell Therapy for Cancer
$716,643Susan Nichols · Falcon Therapeutics, Inc. · R42 · FY2019 · TR
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
$716,510Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2017 · CA
Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma
$716,470Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Quantitative Glioblastoma Margin and Infiltration Mapping with advanced diffusion-relaxation MRI
$715,562Carl-Fredrik Westin · Brigham And Women'S Hospital · R01 · FY2024 · NS
Using implantable microdevices for deep phenotyping of multiple drug responses in brain tumor patients
$714,942Oliver Jonas · Brigham And Women'S Hospital · R01 · FY2025 · CA
Genomics
$714,644Agnes Viale · Sloan-Kettering Inst Can Research · P30 · FY2017 · CA
Imaging and Targeted Auger Radiotherapy of High-Grade Glioma
$714,528Joel Richard Garbow · Washington University · R01 · FY2020 · EB
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$714,336Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$714,336Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$714,052Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Transport Processes and Nervous System Function
$713,593Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors
$713,380Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2021 · CA
SCF as a Novel CNS and Glioma-Derived Angiogenic Factor and SC Chemotaxic Factor
$712,415Howard Fine · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
$712,415Howard Fine · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
$712,415Howard Fine · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$711,759Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
$711,607Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Systems biology of intratumoral heterogeneity in glioblastoma
$710,570Nitin S Baliga · Institute For Systems Biology · R01 · FY2024 · CA
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$710,483Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Using experimentally-guided multi-scale modeling to determining the mechanism of FLASH tissue sparing
$710,252Jan Patrick Oscar Schuemann · Massachusetts General Hospital · R01 · FY2022 · CA
Antibodies, B cells and resistance to human cryptococcosis
$709,959Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2021 · AI